Cargando…
Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for Acinetobacter baumannii Infections
Antibiotic resistance, when it comes to bacterial infections, is not a problem that is going to disappear anytime soon. With the lack of larger investment in novel antibiotic research and the ever-growing increase of resistant isolates amongst the ESKAPEE pathogens (Enterobacter cloacae, Staphylococ...
Autores principales: | Alamneh, Yonas A., Antonic, Vlado, Garry, Brittany, Pucci, Michael J., Abu-Taleb, Rania, Shearer, Jonathan P., Demons, Samandra T., Getnet, Derese, Swierczewski, Brett E., Lister, Troy, Zurawski, Daniel V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495173/ https://www.ncbi.nlm.nih.gov/pubmed/36140032 http://dx.doi.org/10.3390/antibiotics11091251 |
Ejemplares similares
-
SPR741, an Antibiotic Adjuvant, Potentiates the In Vitro and In Vivo Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii
por: Zurawski, Daniel V., et al.
Publicado: (2017) -
A Porcine Wound Model of Acinetobacter baumannii Infection
por: Zurawski, Daniel V., et al.
Publicado: (2019) -
Blast Waves Cause Immune System Dysfunction and Transient Bone Marrow Failure in a Mouse Model
por: Bergmann-Leitner, Elke S., et al.
Publicado: (2022) -
Characterization of Acinetobacter baumannii Copper Resistance Reveals a Role in Virulence
por: Williams, Caitlin L., et al.
Publicado: (2020) -
Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects
por: Eckburg, Paul B., et al.
Publicado: (2019)